The Street downgrades Braze en masse, but options traders keep buying calls

BRZE enters the week after a 57% surge with every major covering analyst moving to the sidelines at once, yet options positioning remains near the most bullish extreme of the past year.

The analyst action on Wednesday was unusually coordinated. Ten firms downgraded Braze on the same day, all citing the rally rather than any deterioration in fundamentals. Barclays cut from Overweight to Equal-Weight while raising its target from $38 to $48. TD Cowen moved from Buy to Hold, lifting its target from $36 to $47.50. Wells Fargo, Stephens, DA Davidson, Stifel, Raymond James, BTIG, Oppenheimer, and Citigroup all followed the same pattern: lower the rating, raise or hold the target near current levels. The consensus now shows 19 Hold ratings and zero Buys. Price targets cluster tightly around $47.50 to $48, barely above the $45.57 close, leaving the Street describing the stock as fairly valued after the run rather than signalling further upside. The EV/EBITDA multiple has expanded roughly 13 points in a week, reflecting the price move rather than any earnings revision.

Options traders are not treating this as a ceiling. The put/call ratio edged up slightly to 0.146 from Tuesday's near-record low of 0.141, but it remains 2.4 standard deviations below its 20-day average of 0.226. That PCR is close to its 52-week low of 0.1409, meaning call buying relative to put buying is still at an extreme not seen in the past year. Six weeks ago the ratio was above 0.38; now there are roughly seven calls traded for every put. The options market is positioned for further gains even as the fundamental analysts are telling clients the easy money has been made.

Short interest tells a quieter story. Shorts covering the float has actually been falling, down from around 11.9% of float in early September to 7.6% now, a 14% decline over the past month. Borrowing costs are negligible at 0.44%, and borrow availability has widened sharply to 879%, meaning for every share currently borrowed there are nearly nine more available to lend. That is not a squeeze setup. Shorts are not being cornered; they are simply holding a smaller position than they did six weeks ago, and the lending market has plenty of room for new short interest to rebuild if sentiment turns.

The broader context adds one more layer. ORTEX forecasts an 84% probability that BRZE will be deleted from the Russell 2000 following a takeover agreement, with an estimated $594 million of index-tracker selling to follow around February 19, 2027, equivalent to roughly 5.3 days of normal volume. Dates are estimated, and this is a forecast rather than an announcement, but a flow of that size in a stock with a $3.4 billion market cap is worth tracking. Among closely correlated peers, APPN gained nearly 15% on the week, TTAN added 12%, and GWRE rose 11%, suggesting the broader enterprise software group has been moving with Braze rather than diverging from it.

The next earnings print is scheduled for December 10. Between now and then, the tension worth watching is whether the call-heavy options positioning persists as the stock trades near the full analyst consensus target, or whether the rating resets prompt a rotation out of calls and back toward neutral.